OrbiMed’s UnitedHealth UNH Stock Holding History

OrbiMed’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$15.6M	–	123
2025 Q2	$15.6M	Buy	+50,000	New	+$19.1M	0.39%	48

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed's UNH Position: Q3 2025 in Review

OrbiMed sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 336,300 shares — an estimated $105M sold.

OrbiMed first reported a position in UNH in Q2 2013 and held it in 40 quarters. The position peaked at $202M in Q4 2022. 3,160 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

OrbiMed reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
OrbiMed sold 336,300 UnitedHealth shares in Q3 2025, an estimated $105M.
OrbiMed first reported a position in UnitedHealth in Q2 2013 and held it in 40 quarters.
OrbiMed's UnitedHealth position peaked at $202M in Q4 2022.
3,160 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on OrbiMed's 13F filing for Q3 2025, filed 14 Nov 2025.